CLINICAL_TRIALS
trial_result
· 2022-02-02
Clinical Trial Update: Study of Investigational Drug in Osteoporosis (MK-0217-908) [Phase 3]
Summary
Phase 3 trial update for investigational drug MK-0217-908 in postmenopausal osteoporosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Postmenopausal Osteoporosis | Phase 3 | Status: COMPLETED